Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

Ryan Richardson joined BioNTech in 2018 and has served as Chief Strategy Officer since January 2020. During his time at the Company, he contributed significantly to BioNTech’s successful development, ...

With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers ...

Pfizer (PFE), a global pharmaceutical giant that was once a pandemic darling, is now facing turbulence. Following a period of extraordinary vaccine-driven revenue, the company now faces a more ...

WASHINGTON, DC / ACCESS Newswire / July 15, 2025 /FairWinds Partners, the world's leading domain name strategy consultancy, ...

Uniquity Bio, a clinical-stage drug development company focused on immunology and inflammation and backed by Blackstone Life Sciences, today announced the appointment of Will Kane as President and CEO ...

How did we get here? Until now, vaccines for all children under age 12 had been available under emergency use authorization ...

Mr. Mahatme brings decades of experience in strategic finance, capital formation, and operational leadership to support ...

Ursula von der Leyen won comfortably - but her next challenge could come from the other end of the political spectrum.

The censure motion, the first of its kind in the European Parliament for over a decade, was initiated by a coalition of far-right lawmakers. For it to succeed, a two-thirds majority vote in favour is ...

European Commission President Ursula von der Leyen survived a no-confidence vote in the European Parliament on Thursday, ...